Benchmarking current nephrectomy practice in malignant disease in England: An analysis of the BAUS complex operation registry
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study
The Lancet Oncology, Volume 21, Issue 1, January 2020, Pages 95-104
Beyond the limits of ultrasound: Three dimensional augmented reality robot assisted partial nephrectomy (3D AR-RAPN) for complex renal masses
Nephrectomy after complete response to immune checkpoint inhibitors for metastatic renal cell carcinoma: A new surgical challenge?
European Urology, January 2020
Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study
November 2019
Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota ‘guilds’ in renal cell carcinoma (RCC) patients
September 2019
Quality of life in previously untreated patients with advanced renal cell carcinoma (aRCC) in CheckMate 214: updated results
, September 2019
Advanced clear-cell renal cell carcinoma (accRCC): association of microRNAs (miRNAs) with molecular subtypes, mRNA targets and outcome
September 2019
First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (nccRCC): updated follow-up for keynote-427 cohort b
September 2019
Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota guilds in renal cell carcinoma (RCC) patients
September 2019
Tumour seeding in the tract of percutaneous renal tumour biopsy: a report on seven cases from a UK tertiary referral centre
European Urology, Volume 75, Issue 5, May 2019, Pages 861-867
The ERUS curriculum for robot-assisted partial nephrectomy: structure definition and pilot clinical validation
European Urology, Volume 75, Issue 6, June 2019, Pages 1023-1031
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy. I agree Read More